Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery

Elisabeth Mahla, Helfried Metzler, Udaya S. Tantry, Paul A. Gurbel

Research output: Contribution to journalArticle

Abstract

Oral antiplatelet therapy with aspirin and clopidogrel is a major strategy to prevent thrombotic events in patients with acute coronary syndromes and patients undergoing percutaneous coronary interventions. Although this therapy is associated with both short- and long-term clinical efficacy, irreversible platelet inhibition and ischemic events associated with premature withdrawal especially in patients treated with drug-eluting stents constitute a particular limitation in patients undergoing surgery. The current review article is focused on the central role of platelets in the occurrence of ischemic events, the significance of antiplatelet therapy, the potential hazards of drug withdrawal in patients needing coronary artery bypass grafting, and future perspectives.

Original languageEnglish (US)
Pages (from-to)1040-1051
Number of pages12
JournalAnnals of Thoracic Surgery
Volume90
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Coronary Artery Bypass
clopidogrel
Blood Platelets
Therapeutics
Drug-Eluting Stents
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Aspirin
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. / Mahla, Elisabeth; Metzler, Helfried; Tantry, Udaya S.; Gurbel, Paul A.

In: Annals of Thoracic Surgery, Vol. 90, No. 3, 2010, p. 1040-1051.

Research output: Contribution to journalArticle

Mahla, Elisabeth ; Metzler, Helfried ; Tantry, Udaya S. ; Gurbel, Paul A. / Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. In: Annals of Thoracic Surgery. 2010 ; Vol. 90, No. 3. pp. 1040-1051.
@article{3f98a9a566f94e8ca8c886e1ca37380d,
title = "Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery",
abstract = "Oral antiplatelet therapy with aspirin and clopidogrel is a major strategy to prevent thrombotic events in patients with acute coronary syndromes and patients undergoing percutaneous coronary interventions. Although this therapy is associated with both short- and long-term clinical efficacy, irreversible platelet inhibition and ischemic events associated with premature withdrawal especially in patients treated with drug-eluting stents constitute a particular limitation in patients undergoing surgery. The current review article is focused on the central role of platelets in the occurrence of ischemic events, the significance of antiplatelet therapy, the potential hazards of drug withdrawal in patients needing coronary artery bypass grafting, and future perspectives.",
author = "Elisabeth Mahla and Helfried Metzler and Tantry, {Udaya S.} and Gurbel, {Paul A.}",
year = "2010",
doi = "10.1016/j.athoracsur.2010.04.041",
language = "English (US)",
volume = "90",
pages = "1040--1051",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery

AU - Mahla, Elisabeth

AU - Metzler, Helfried

AU - Tantry, Udaya S.

AU - Gurbel, Paul A.

PY - 2010

Y1 - 2010

N2 - Oral antiplatelet therapy with aspirin and clopidogrel is a major strategy to prevent thrombotic events in patients with acute coronary syndromes and patients undergoing percutaneous coronary interventions. Although this therapy is associated with both short- and long-term clinical efficacy, irreversible platelet inhibition and ischemic events associated with premature withdrawal especially in patients treated with drug-eluting stents constitute a particular limitation in patients undergoing surgery. The current review article is focused on the central role of platelets in the occurrence of ischemic events, the significance of antiplatelet therapy, the potential hazards of drug withdrawal in patients needing coronary artery bypass grafting, and future perspectives.

AB - Oral antiplatelet therapy with aspirin and clopidogrel is a major strategy to prevent thrombotic events in patients with acute coronary syndromes and patients undergoing percutaneous coronary interventions. Although this therapy is associated with both short- and long-term clinical efficacy, irreversible platelet inhibition and ischemic events associated with premature withdrawal especially in patients treated with drug-eluting stents constitute a particular limitation in patients undergoing surgery. The current review article is focused on the central role of platelets in the occurrence of ischemic events, the significance of antiplatelet therapy, the potential hazards of drug withdrawal in patients needing coronary artery bypass grafting, and future perspectives.

UR - http://www.scopus.com/inward/record.url?scp=77956152164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956152164&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2010.04.041

DO - 10.1016/j.athoracsur.2010.04.041

M3 - Article

C2 - 20732553

AN - SCOPUS:77956152164

VL - 90

SP - 1040

EP - 1051

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -